Creo Medical Group (LON:CREO) Trading Up 3.6% – What’s Next?

Creo Medical Group PLC (LON:CREO) traded up 3.6% during trading on Thursday . The stock traded as high as GBX 13 and last traded at GBX 12.56. 728,823 shares were traded during mid-day trading, a decline of 13% from the average session volume of 837,861 shares. The stock had previously closed at GBX 12.13.

Analyst Ratings Changes

Separately, Shore Capital Group reaffirmed a “house stock” rating on shares of Creo Medical Group in a report on Thursday, April 16th.

Creo Medical Group Stock Performance

The stock has a market capitalization of £51.81 million, a P/E ratio of -12.56 and a beta of 1.50. The company’s 50-day moving average is GBX 12.60 and its two-hundred day moving average is GBX 12.10. The company has a current ratio of 5.28, a quick ratio of 2.19 and a debt-to-equity ratio of 6.90.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.